Published in Perfusion on March 01, 1997
Mycobacterium paratuberculosis CobT activates dendritic cells via engagement of Toll-like receptor 4 resulting in Th1 cell expansion. J Biol Chem (2012) 0.82
PPE26 induces TLR2-dependent activation of macrophages and drives Th1-type T-cell immunity by triggering the cross-talk of multiple pathways involved in the host response. Oncotarget (2015) 0.80
Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity. J Biomater Appl (2014) 0.75
Eosinophilic inflammation in asthma. N Engl J Med (1990) 8.05
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med (2000) 4.35
Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis (1985) 3.77
Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation (1996) 2.91
Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol (2001) 2.87
Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature (1986) 2.41
Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden. J Intern Med (2010) 2.30
Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells. Blood (1974) 2.22
Antidepressant use and risk of out-of-hospital cardiac arrest: a nationwide case-time-control study. Clin Pharmacol Ther (2012) 2.20
Lipocalins as biochemical markers of disease. Biochim Biophys Acta (2000) 2.08
Cellular cooperation in endothelial cell thromboplastin synthesis. Br J Haematol (1983) 2.05
Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy (2004) 2.03
Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol (1997) 1.98
An outbreak of group B meningococcal disease: tracing the causative strain of Neisseria meningitidis by DNA fingerprinting. J Clin Microbiol (1986) 1.88
Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature (1984) 1.75
Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med (1999) 1.69
Radioimmunoassay of human eosinophil cationic protein. Br J Haematol (1977) 1.68
Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma. Clin Exp Allergy (1993) 1.65
Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group. Eur Heart J (1997) 1.65
A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer. Eur J Cancer (2012) 1.64
Laparoscopic resection of the pancreas: a feasibility study of the short-term outcome. Surg Endosc (2004) 1.59
Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. Am J Respir Crit Care Med (2000) 1.58
Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes. Lab Invest (1977) 1.57
Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J Clin Invest (1980) 1.56
Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium. Acta Radiol (2001) 1.55
The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung. Clin Exp Allergy (1999) 1.55
Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus--a retrospective nationwide study. Diabetes Obes Metab (2014) 1.54
Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand J Clin Lab Invest (1995) 1.51
Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta (2011) 1.49
High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes. Ann Thorac Surg (1995) 1.48
Cardiac fibrinolytic capacity is markedly increased after brief periods of local myocardial ischemia, but declines following successive periods in anesthetized pigs. J Thromb Haemost (2005) 1.48
Aminoethyl-isothiourea, a nitric oxide synthase inhibitor and oxygen radical scavenger, improves survival and counteracts hemodynamic deterioration in a porcine model of streptococcal shock. Crit Care Med (2000) 1.47
The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer. Br J Haematol (1997) 1.47
Viral safety of solvent/detergent-treated plasma. Transfusion (2000) 1.46
Granulocytes and their secretory products, myeloperoxidase and eosinophil cationic protein, in bronchoalveolar lavage fluids from two lung lobes in normal subjects. Eur Respir J (1991) 1.45
Different oxygenators for cardiopulmonary bypass lead to varying degrees of human complement activation in vitro. J Thorac Cardiovasc Surg (1989) 1.45
Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut (2002) 1.45
Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. Am J Respir Crit Care Med (1996) 1.44
Aminoethyl-isothiourea inhibits the increase in plasma endothelin-1 caused by serogroup A streptococci and prolongs survival in rat peritoneal sepsis. Shock (2001) 1.43
Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. J Immunol (1983) 1.43
Surface characteristics of the U-937 human histiocytic lymphoma cell line: specific changes during inducible morphologic and functional differentiation in vitro. Haematol Blood Transfus (1981) 1.42
IL-5 priming of the PMA-induced oxidative metabolism of human eosinophils from allergic and normal subjects during a pollen season. Clin Exp Allergy (2001) 1.41
Activation of B-lymphocytes during pollen season. Effect of immunotherapy. Clin Exp Allergy (1998) 1.40
The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X. J Allergy Clin Immunol (1982) 1.40
Eosinophil granule proteins in cardiopulmonary bypass with and without heparin coating. Ann Thorac Surg (1995) 1.40
A magnetic resonance imaging study of modifications to the infraclavicular brachial plexus block. Anesth Analg (2000) 1.39
Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am Rev Respir Dis (1993) 1.39
Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol (1997) 1.37
Human eosinophil peroxidase: purification and characterization. J Immunol (1985) 1.36
Obesity increases the risk of incident asthma among adults. Eur Respir J (2005) 1.33
Stimulation of degranulation from human eosinophils by platelet-activating factor. J Immunol (1989) 1.32
Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis (1990) 1.31
Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines. Am J Physiol (1988) 1.30
Enhancement of factor XII dependent reactions by eosinophil cationic protein. Thromb Res (1979) 1.30
Cationic proteins of human granulocytes. IV. Esterase activity. Lab Invest (1975) 1.28
A comparative study of the short-term outcome following open and laparoscopic liver resection of colorectal metastases. Surg Endosc (2002) 1.27
In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodontol (1997) 1.27
Serum myeloperoxidase and lactoferrin in neutropenia. Scand J Haematol (1977) 1.25
Work stress and low emotional support is associated with increased risk of future type 2 diabetes in women. Diabetes Res Clin Pract (2006) 1.25
Kinetic studies of phagocytosis. I. The serum independent particle uptake by PMN from patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum (1978) 1.24
Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. Scand J Clin Lab Invest (1994) 1.23
Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort. J Thromb Haemost (2011) 1.23
Kinetic studies of phagocytosis of IgG-coated latex particles with a thrombocyte counter. J Lab Clin Med (1977) 1.22
The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function. Am Rev Respir Dis (1989) 1.21
Toxic effects of methylmethacrylate monomer on leukocytes and endothelial cells in vitro. Acta Orthop Scand (1994) 1.20
Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative. J Clin Periodontol (2001) 1.20
Variations of blood eosinophils and eosinophil cationic protein in serum in patients with bronchial asthma. Studies during inhalation challenge test. Allergy (1978) 1.19
Guidance for the safety assessment of botanicals and botanical preparations for use in food and food supplements. Food Chem Toxicol (2003) 1.19
Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT. Respir Med (2001) 1.18
Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol (1991) 1.17
Neutrophils from term and preterm newborn infants express the high affinity Fcgamma-receptor I (CD64) during bacterial infections. Pediatr Res (1999) 1.16
The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. J Allergy Clin Immunol (1988) 1.15
Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clin Exp Allergy (1991) 1.15
Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity. J Immunol (1975) 1.15
Selection bias in a study on how women experienced induced abortion. Eur J Obstet Gynecol Reprod Biol (1998) 1.14
Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol (1990) 1.14
The pancreas transplant program--Gothenburg, Sweden. Transplant Proc (1987) 1.13
IL-5 and TNF-alpha participate in recruitment of eosinophils to intestinal mucosa in ulcerative colitis. Dig Dis Sci (2001) 1.12
Time to revise the paradigm of hantavirus syndromes? Hantavirus pulmonary syndrome caused by European hantavirus. Eur J Clin Microbiol Infect Dis (2011) 1.12
Studies on the phagocytic activity of the granulocytes in psoriasis and palmoplantar pustulosis. Br J Dermatol (1983) 1.11
Neutrophil and eosinophil granulocytes in bacterial infection: sequential studies of cellular and serum levels of granule proteins. Br J Haematol (1978) 1.11
Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Genet (1994) 1.10
The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ. Oncogene (2008) 1.10
Nasal and ocular symptoms, tear film stability and biomarkers in nasal lavage, in relation to building-dampness and building design in hospitals. Int Arch Occup Environ Health (1999) 1.10
A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed. J Intern Med (2006) 1.10
Beta microseminoprotein is not a prostate-specific protein. Its identification in mucous glands and secretions. Am J Pathol (1990) 1.09
Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J Allergy Clin Immunol (1996) 1.09
Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity. Inflammation (1990) 1.09
Effects of serum and cations on the selective release of granular proteins from human netrophils during phagocytosis. Scand J Haematol (1979) 1.08
Extreme hyperbilirubinaemia in term and near-term infants in Denmark. Acta Paediatr (2005) 1.08
Cationic proteins of human granulocytes. I. Isolation of the cationic proteins from the granules of leukaemic myeloid cells. Scand J Haematol (1972) 1.07
Effect of hyaluronic acid on phagocytosis of opsonized latex particles. Scand J Immunol (1980) 1.07
Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers. Int J Biochem Cell Biol (2001) 1.07
Oestrogen receptor analysis of paraffin sections and cytosol samples of primary breast cancer in relation to outcome after adjuvant tamoxifen treatment. The South Sweden Breast Cancer Group. Acta Oncol (1996) 1.07
The role of the human neutrophil in the inflammatory reaction. Allergy (1980) 1.06
Changes in plasma IL-1beta, TNF-alpha and IL-6 after total hip replacement surgery in general or regional anaesthesia. Cytokine (2000) 1.06
Radioimmunoassay of beta-microseminoprotein, a prostatic-secreted protein present in sera of both men and women. Clin Chem (1989) 1.06